LLY (LLY) Stock Analysis

LLY (LLY) is a publicly traded company in the HEALTHCARE sector. It trades at $1065.12, carries a market capitalization of $965.04B, a price-to-earnings ratio of 38.46. This page summarizes the public market data, fundamentals, and frequently asked questions for LLY, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $1065.12
• Market Cap: $965.04B
• P/E Ratio: 38.46
• EPS: $28.14
• 52-Week High: $1149.10
• 52-Week Low: $619.40

Market Sentiment

LLY currently has a Bullish sentiment score of 0.26.

About LLY

Eli Lilly and Company (Ticker: LLY), headquartered in Indianapolis, Indiana, is a prominent global pharmaceutical leader recognized for its commitment to innovation in healthcare. With a robust portfolio focused on critical therapeutic areas such as diabetes, oncology, and neurodegenerative disorders, Lilly operates in approximately 125 countries and aims to improve patient outcomes through significant research investments. The company's strategic focus on sustainable growth, complemented by ...

GNG Research Analysis

GNG Research scores LLY (LLY) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for LLY.

Frequently Asked Questions

Does LLY pay dividends?

LLY (LLY) does not currently pay a regular dividend.

What is LLY's P/E ratio?

LLY has a price-to-earnings (P/E) ratio of 38.46.

What is LLY's market cap?

LLY (LLY) has a market capitalization of $965.04B with a current stock price of $1065.12.